

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.47407873 |
| 2 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 6.43013230 |
| 3 | regulation of cardioblast proliferation (GO:0003264) | 6.43013230 |
| 4 | outer ear morphogenesis (GO:0042473) | 6.04293803 |
| 5 | pharyngeal system development (GO:0060037) | 5.98174169 |
| 6 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.68409474 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 5.36558137 |
| 8 | central nervous system myelination (GO:0022010) | 5.36558137 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.35699843 |
| 10 | regulation of DNA endoreduplication (GO:0032875) | 5.30864011 |
| 11 | sulfation (GO:0051923) | 5.28781837 |
| 12 | regulation of glomerulus development (GO:0090192) | 5.24838186 |
| 13 | regulation of cell proliferation involved in kidney development (GO:1901722) | 5.19665619 |
| 14 | cellular response to ATP (GO:0071318) | 5.17169330 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 4.89759300 |
| 16 | presynaptic membrane assembly (GO:0097105) | 4.77599339 |
| 17 | cell proliferation in forebrain (GO:0021846) | 4.73849165 |
| 18 | serotonin metabolic process (GO:0042428) | 4.73165353 |
| 19 | positive regulation of fatty acid oxidation (GO:0046321) | 4.60979335 |
| 20 | cellular anion homeostasis (GO:0030002) | 4.58888701 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.47601780 |
| 22 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.40286751 |
| 23 | tooth mineralization (GO:0034505) | 4.39960910 |
| 24 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.33064642 |
| 25 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.31194381 |
| 26 | aorta morphogenesis (GO:0035909) | 4.31159480 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.30248746 |
| 28 | fatty acid elongation (GO:0030497) | 4.27876613 |
| 29 | positive regulation of metanephros development (GO:0072216) | 4.27077439 |
| 30 | negative regulation of neurotransmitter transport (GO:0051589) | 4.26312951 |
| 31 | primary amino compound metabolic process (GO:1901160) | 4.03111319 |
| 32 | negative regulation of appetite (GO:0032099) | 4.02183541 |
| 33 | negative regulation of response to food (GO:0032096) | 4.02183541 |
| 34 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.90203638 |
| 35 | membrane repolarization during action potential (GO:0086011) | 3.86731250 |
| 36 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.77144412 |
| 37 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64959274 |
| 38 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.62109661 |
| 39 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.61429030 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.60491952 |
| 41 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.60167753 |
| 42 | cellular response to exogenous dsRNA (GO:0071360) | 3.52641526 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47604655 |
| 44 | membrane depolarization during action potential (GO:0086010) | 3.43937492 |
| 45 | regulation of sequestering of triglyceride (GO:0010889) | 3.38055813 |
| 46 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 3.37195720 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.34849427 |
| 48 | dopamine transport (GO:0015872) | 3.34822392 |
| 49 | interkinetic nuclear migration (GO:0022027) | 3.34609639 |
| 50 | lung epithelial cell differentiation (GO:0060487) | 3.34568793 |
| 51 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.32063018 |
| 52 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.32063018 |
| 53 | response to UV-C (GO:0010225) | 3.30834946 |
| 54 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.29918732 |
| 55 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.29294922 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28780930 |
| 57 | musculoskeletal movement (GO:0050881) | 3.28601752 |
| 58 | multicellular organismal movement (GO:0050879) | 3.28601752 |
| 59 | indole-containing compound metabolic process (GO:0042430) | 3.26191413 |
| 60 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.21846147 |
| 61 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.21242518 |
| 62 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.20868587 |
| 63 | neuron remodeling (GO:0016322) | 3.20118254 |
| 64 | neuronal action potential propagation (GO:0019227) | 3.19704525 |
| 65 | regulation of organ formation (GO:0003156) | 3.17331205 |
| 66 | flavonoid metabolic process (GO:0009812) | 3.16462661 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 3.15860744 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.15860744 |
| 69 | lung cell differentiation (GO:0060479) | 3.14113852 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.11249093 |
| 71 | myelination (GO:0042552) | 3.09712760 |
| 72 | transmission of nerve impulse (GO:0019226) | 3.09686353 |
| 73 | negative regulation of hormone metabolic process (GO:0032351) | 3.08539576 |
| 74 | axon ensheathment (GO:0008366) | 3.06572464 |
| 75 | ensheathment of neurons (GO:0007272) | 3.06572464 |
| 76 | mast cell activation (GO:0045576) | 3.05633274 |
| 77 | positive regulation of gluconeogenesis (GO:0045722) | 3.04918495 |
| 78 | neurotransmitter uptake (GO:0001504) | 3.02958361 |
| 79 | regulation of gene silencing by RNA (GO:0060966) | 3.01929681 |
| 80 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.01929681 |
| 81 | regulation of gene silencing by miRNA (GO:0060964) | 3.01929681 |
| 82 | tryptophan catabolic process (GO:0006569) | 3.00010853 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 3.00010853 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 3.00010853 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 2.99802816 |
| 86 | chaperone-mediated protein transport (GO:0072321) | 2.97820079 |
| 87 | parturition (GO:0007567) | 2.96260387 |
| 88 | regulation of metanephros development (GO:0072215) | 2.95229668 |
| 89 | dentate gyrus development (GO:0021542) | 2.94380540 |
| 90 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.93151547 |
| 91 | negative chemotaxis (GO:0050919) | 2.90732488 |
| 92 | metanephros development (GO:0001656) | 2.90457464 |
| 93 | negative regulation of platelet activation (GO:0010544) | 2.90406012 |
| 94 | dopamine biosynthetic process (GO:0042416) | 2.89871531 |
| 95 | otic vesicle formation (GO:0030916) | 2.89680333 |
| 96 | mast cell degranulation (GO:0043303) | 2.87529170 |
| 97 | mast cell activation involved in immune response (GO:0002279) | 2.87529170 |
| 98 | regulation of dopamine metabolic process (GO:0042053) | 2.87139161 |
| 99 | regulation of catecholamine metabolic process (GO:0042069) | 2.87139161 |
| 100 | mannosylation (GO:0097502) | 2.86898003 |
| 101 | lymphoid progenitor cell differentiation (GO:0002320) | 2.86349748 |
| 102 | GPI anchor biosynthetic process (GO:0006506) | 2.86319523 |
| 103 | regulation of heart morphogenesis (GO:2000826) | 2.85321317 |
| 104 | kynurenine metabolic process (GO:0070189) | 2.85104430 |
| 105 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.84405895 |
| 106 | middle ear morphogenesis (GO:0042474) | 2.83852269 |
| 107 | synaptic vesicle exocytosis (GO:0016079) | 2.83821327 |
| 108 | glutamate receptor signaling pathway (GO:0007215) | 2.83797980 |
| 109 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.81228087 |
| 110 | cellular response to epinephrine stimulus (GO:0071872) | 2.80376191 |
| 111 | substantia nigra development (GO:0021762) | 2.79437571 |
| 112 | protein localization to synapse (GO:0035418) | 2.75916891 |
| 113 | regulation of germinal center formation (GO:0002634) | 2.75654217 |
| 114 | respiratory electron transport chain (GO:0022904) | 2.74373084 |
| 115 | spinal cord motor neuron differentiation (GO:0021522) | 2.73913110 |
| 116 | protein sumoylation (GO:0016925) | 2.73416995 |
| 117 | regulation of glutamate secretion (GO:0014048) | 2.73394365 |
| 118 | membrane repolarization (GO:0086009) | 2.72695600 |
| 119 | amyloid precursor protein metabolic process (GO:0042982) | 2.72614862 |
| 120 | membrane assembly (GO:0071709) | 2.70813845 |
| 121 | regulation of hippo signaling (GO:0035330) | 2.70025524 |
| 122 | electron transport chain (GO:0022900) | 2.69452089 |
| 123 | vocalization behavior (GO:0071625) | 2.68955129 |
| 124 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.68041491 |
| 125 | fucose catabolic process (GO:0019317) | 2.67918028 |
| 126 | L-fucose metabolic process (GO:0042354) | 2.67918028 |
| 127 | L-fucose catabolic process (GO:0042355) | 2.67918028 |
| 128 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.67818120 |
| 129 | neuron fate specification (GO:0048665) | 2.66690202 |
| 130 | catecholamine transport (GO:0051937) | 2.65856657 |
| 131 | postsynaptic membrane organization (GO:0001941) | 2.65704994 |
| 132 | cell differentiation in hindbrain (GO:0021533) | 2.64937934 |
| 133 | response to epinephrine (GO:0071871) | 2.63883577 |
| 134 | reflex (GO:0060004) | 2.62667635 |
| 135 | GPI anchor metabolic process (GO:0006505) | 2.60987015 |
| 136 | behavioral response to pain (GO:0048266) | 2.60490583 |
| 137 | phagosome maturation (GO:0090382) | 2.60038273 |
| 138 | positive regulation of synapse assembly (GO:0051965) | 2.60033582 |
| 139 | response to histamine (GO:0034776) | 2.59693770 |
| 140 | neuron-neuron synaptic transmission (GO:0007270) | 2.59204982 |
| 141 | regulation of axon regeneration (GO:0048679) | 2.57971860 |
| 142 | regulation of neuron projection regeneration (GO:0070570) | 2.57971860 |
| 143 | prostate gland growth (GO:0060736) | 2.56103854 |
| 144 | regulation of response to food (GO:0032095) | 2.55324682 |
| 145 | multicellular organismal signaling (GO:0035637) | 2.54946922 |
| 146 | regulation of collateral sprouting (GO:0048670) | 2.53934035 |
| 147 | calcium ion import (GO:0070509) | 2.53928951 |
| 148 | positive regulation of Notch signaling pathway (GO:0045747) | 2.52592395 |
| 149 | regulation of membrane repolarization (GO:0060306) | 2.52570095 |
| 150 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.52285497 |
| 151 | positive regulation of digestive system process (GO:0060456) | 2.51164886 |
| 152 | protein polyglutamylation (GO:0018095) | 2.50510082 |
| 153 | angiogenesis involved in wound healing (GO:0060055) | 2.50486621 |
| 154 | regulation of mesoderm development (GO:2000380) | 2.49992049 |
| 155 | activated T cell proliferation (GO:0050798) | 2.49356707 |
| 156 | response to methylmercury (GO:0051597) | 2.48529354 |
| 157 | neuronal action potential (GO:0019228) | 2.48164262 |
| 158 | regulation of appetite (GO:0032098) | 2.47592912 |
| 159 | protein neddylation (GO:0045116) | 2.47264993 |
| 160 | neutrophil activation involved in immune response (GO:0002283) | 2.47015401 |
| 161 | cardiovascular system development (GO:0072358) | 2.46984264 |
| 162 | glycolipid biosynthetic process (GO:0009247) | 2.46757767 |
| 163 | synaptic transmission, dopaminergic (GO:0001963) | 2.44834859 |
| 164 | developmental pigmentation (GO:0048066) | 2.44232051 |
| 165 | positive regulation of action potential (GO:0045760) | 2.43131642 |
| 166 | serotonin receptor signaling pathway (GO:0007210) | 2.42048027 |
| 167 | leukocyte degranulation (GO:0043299) | 2.41486636 |
| 168 | regulation of feeding behavior (GO:0060259) | 2.40051588 |
| 169 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.39631263 |
| 170 | negative regulation of exocytosis (GO:0045920) | 2.39259119 |
| 171 | neuron recognition (GO:0008038) | 2.38607404 |
| 172 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.38279109 |
| 173 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.38279109 |
| 174 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.37431726 |
| 175 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.37287264 |
| 176 | NADH dehydrogenase complex assembly (GO:0010257) | 2.37287264 |
| 177 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.37287264 |
| 178 | adult walking behavior (GO:0007628) | 2.36662329 |
| 179 | cholesterol biosynthetic process (GO:0006695) | 2.36424636 |
| 180 | protein complex biogenesis (GO:0070271) | 2.34845687 |
| 181 | regulated secretory pathway (GO:0045055) | 2.34362259 |
| 182 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33343905 |
| 183 | negative regulation of cell killing (GO:0031342) | 2.33343905 |
| 184 | negative regulation of synaptic transmission (GO:0050805) | 2.33167992 |
| 185 | regulation of vesicle fusion (GO:0031338) | 2.32465999 |
| 186 | oligodendrocyte differentiation (GO:0048709) | 2.31825829 |
| 187 | synaptic transmission, glutamatergic (GO:0035249) | 2.31084651 |
| 188 | intracellular pH reduction (GO:0051452) | 2.30635948 |
| 189 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.30407068 |
| 190 | regulation of pigment cell differentiation (GO:0050932) | 2.30335665 |
| 191 | protein localization to cilium (GO:0061512) | 2.29157974 |
| 192 | regulation of memory T cell differentiation (GO:0043380) | 2.28226871 |
| 193 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.27776506 |
| 194 | magnesium ion transport (GO:0015693) | 2.27261256 |
| 195 | cerebellar granule cell differentiation (GO:0021707) | 2.26457847 |
| 196 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.26272755 |
| 197 | glycosphingolipid biosynthetic process (GO:0006688) | 2.26078448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.88315960 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.78217951 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.61251084 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.38875380 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.59534939 |
| 6 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53666807 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42787695 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39194081 |
| 9 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.38534132 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.34286143 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33961437 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33537804 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.10160753 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07259177 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.05226509 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00669521 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.00446052 |
| 18 | P300_19829295_ChIP-Seq_ESCs_Human | 1.99255215 |
| 19 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95329239 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94494794 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92442952 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92131746 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89359350 |
| 24 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86063212 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83948011 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83410629 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78111500 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78107974 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.73724858 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73203016 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73143048 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72936812 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70093822 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.67540656 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64853313 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61932750 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59962804 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58701005 |
| 39 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.58274738 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57323333 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56906823 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56268150 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55076488 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53842720 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53053325 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52144500 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51205349 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48612575 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48602241 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.48059644 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48041442 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46792190 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46792190 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45241815 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44671196 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43869066 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42864308 |
| 58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42199117 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41829370 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38952089 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36004591 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35870961 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35028742 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34917188 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34853463 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31787430 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.31502838 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29161707 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28635672 |
| 70 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27418696 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25900326 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25883934 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25820644 |
| 74 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25356340 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24950266 |
| 76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24838489 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24689609 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23200936 |
| 79 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.22627472 |
| 80 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20714873 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20371785 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20320739 |
| 83 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20306703 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20132724 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20132724 |
| 86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18198519 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18189939 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17558139 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16311901 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15975776 |
| 91 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.14531199 |
| 92 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13435236 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 1.12566562 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12020961 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11385128 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11143436 |
| 97 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10864284 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10099826 |
| 99 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10031138 |
| 100 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09708418 |
| 101 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09659936 |
| 102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09307451 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09082006 |
| 104 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08642360 |
| 105 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07780109 |
| 106 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07648562 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07160593 |
| 108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06872909 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06772888 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06772888 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06618192 |
| 112 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05645363 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05383833 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04309823 |
| 115 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.04122563 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03566993 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01749123 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01730675 |
| 119 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01665312 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01649978 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01099537 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99289330 |
| 123 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99091679 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98970300 |
| 125 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98358238 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98155239 |
| 127 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98059514 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98038134 |
| 129 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97875207 |
| 130 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97795922 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97068871 |
| 132 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.97058895 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96538957 |
| 134 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95276829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.03303984 |
| 2 | MP0000678_abnormal_parathyroid_gland | 4.03651299 |
| 3 | MP0004134_abnormal_chest_morphology | 3.29481972 |
| 4 | MP0000920_abnormal_myelination | 2.91404473 |
| 5 | MP0001529_abnormal_vocalization | 2.87341512 |
| 6 | MP0001905_abnormal_dopamine_level | 2.85182580 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 2.83117980 |
| 8 | MP0004130_abnormal_muscle_cell | 2.72647773 |
| 9 | MP0002249_abnormal_larynx_morphology | 2.71932396 |
| 10 | MP0000631_abnormal_neuroendocrine_gland | 2.70476291 |
| 11 | MP0005409_darkened_coat_color | 2.68218289 |
| 12 | MP0009745_abnormal_behavioral_response | 2.65583644 |
| 13 | MP0002064_seizures | 2.58822167 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.55825188 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.50475744 |
| 16 | MP0002272_abnormal_nervous_system | 2.50354647 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.43019345 |
| 18 | MP0009250_abnormal_appendicular_skeleto | 2.42733579 |
| 19 | MP0009046_muscle_twitch | 2.38974854 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.37008383 |
| 21 | MP0000049_abnormal_middle_ear | 2.34233485 |
| 22 | MP0004270_analgesia | 2.29507842 |
| 23 | MP0001188_hyperpigmentation | 2.24208418 |
| 24 | MP0000681_abnormal_thyroid_gland | 2.17853980 |
| 25 | MP0003938_abnormal_ear_development | 2.16831105 |
| 26 | MP0003646_muscle_fatigue | 2.15883147 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.12782098 |
| 28 | MP0003879_abnormal_hair_cell | 2.12265856 |
| 29 | MP0005423_abnormal_somatic_nervous | 2.11331635 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 2.10518893 |
| 31 | MP0002160_abnormal_reproductive_system | 2.09645639 |
| 32 | MP0003195_calcinosis | 2.08896580 |
| 33 | MP0002736_abnormal_nociception_after | 2.08559835 |
| 34 | MP0002735_abnormal_chemical_nociception | 2.08007889 |
| 35 | MP0006276_abnormal_autonomic_nervous | 2.02612751 |
| 36 | MP0004142_abnormal_muscle_tone | 2.01768022 |
| 37 | MP0001486_abnormal_startle_reflex | 1.99314084 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.92710512 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.91863336 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.88439711 |
| 41 | MP0004147_increased_porphyrin_level | 1.86284330 |
| 42 | MP0003329_amyloid_beta_deposits | 1.83130693 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.81896316 |
| 44 | MP0003724_increased_susceptibility_to | 1.69543756 |
| 45 | MP0001970_abnormal_pain_threshold | 1.68201524 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.66745045 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.65082351 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.62389002 |
| 49 | MP0003942_abnormal_urinary_system | 1.61445123 |
| 50 | MP0001177_atelectasis | 1.61097759 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.60999254 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.60055938 |
| 53 | MP0000534_abnormal_ureter_morphology | 1.59252545 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 1.55147205 |
| 55 | MP0003690_abnormal_glial_cell | 1.53393393 |
| 56 | MP0004924_abnormal_behavior | 1.53299217 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.53299217 |
| 58 | MP0005671_abnormal_response_to | 1.52150268 |
| 59 | MP0005389_reproductive_system_phenotype | 1.51633249 |
| 60 | MP0003638_abnormal_response/metabolism_ | 1.49929737 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.49605423 |
| 62 | MP0004742_abnormal_vestibular_system | 1.49234012 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.43415776 |
| 64 | MP0001853_heart_inflammation | 1.40994794 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 1.40340265 |
| 66 | MP0002822_catalepsy | 1.39049637 |
| 67 | MP0008569_lethality_at_weaning | 1.37160639 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.37142914 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.35618875 |
| 70 | MP0002928_abnormal_bile_duct | 1.34698993 |
| 71 | MP0000026_abnormal_inner_ear | 1.33739548 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.33141009 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 1.29139951 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.22200861 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.21401599 |
| 76 | * MP0009785_altered_susceptibility_to | 1.20285318 |
| 77 | MP0000778_abnormal_nervous_system | 1.19813047 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.17953543 |
| 79 | MP0002229_neurodegeneration | 1.17901065 |
| 80 | MP0005171_absent_coat_pigmentation | 1.16856055 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.16775335 |
| 82 | MP0002876_abnormal_thyroid_physiology | 1.15155935 |
| 83 | * MP0005025_abnormal_response_to | 1.11916148 |
| 84 | MP0001790_abnormal_immune_system | 1.11772862 |
| 85 | MP0005387_immune_system_phenotype | 1.11772862 |
| 86 | MP0000604_amyloidosis | 1.10784741 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 1.09623341 |
| 88 | MP0003633_abnormal_nervous_system | 1.09246771 |
| 89 | MP0009384_cardiac_valve_regurgitation | 1.08545131 |
| 90 | MP0003136_yellow_coat_color | 1.06564432 |
| 91 | MP0004133_heterotaxia | 1.06312887 |
| 92 | MP0001765_abnormal_ion_homeostasis | 1.05727610 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.05150869 |
| 94 | MP0003631_nervous_system_phenotype | 1.04807362 |
| 95 | MP0004381_abnormal_hair_follicle | 1.04292312 |
| 96 | MP0003634_abnormal_glial_cell | 1.04064332 |
| 97 | MP0000372_irregular_coat_pigmentation | 1.03359210 |
| 98 | * MP0002419_abnormal_innate_immunity | 1.02789539 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 1.02760093 |
| 100 | MP0002557_abnormal_social/conspecific_i | 1.02560822 |
| 101 | MP0005646_abnormal_pituitary_gland | 1.02377802 |
| 102 | MP0002723_abnormal_immune_serum | 1.02288744 |
| 103 | MP0003183_abnormal_peptide_metabolism | 1.02278860 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 1.02179736 |
| 105 | MP0001984_abnormal_olfaction | 0.98110001 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.96890346 |
| 107 | MP0008874_decreased_physiological_sensi | 0.95637899 |
| 108 | * MP0002420_abnormal_adaptive_immunity | 0.95496679 |
| 109 | MP0005310_abnormal_salivary_gland | 0.95411876 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.94308072 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.94192167 |
| 112 | MP0002184_abnormal_innervation | 0.93893190 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.93593775 |
| 114 | MP0003787_abnormal_imprinting | 0.93581612 |
| 115 | * MP0001819_abnormal_immune_cell | 0.92823000 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.91474274 |
| 117 | MP0003632_abnormal_nervous_system | 0.91244011 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.91104934 |
| 119 | MP0001800_abnormal_humoral_immune | 0.90588796 |
| 120 | MP0000685_abnormal_immune_system | 0.90226722 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.90177484 |
| 122 | MP0006082_CNS_inflammation | 0.89715786 |
| 123 | MP0002396_abnormal_hematopoietic_system | 0.88538893 |
| 124 | MP0005448_abnormal_energy_balance | 0.87062293 |
| 125 | MP0001851_eye_inflammation | 0.86447081 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.85787079 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.85389208 |
| 128 | MP0002932_abnormal_joint_morphology | 0.85148674 |
| 129 | MP0002102_abnormal_ear_morphology | 0.84611544 |
| 130 | MP0008260_abnormal_autophagy | 0.84568885 |
| 131 | MP0001542_abnormal_bone_strength | 0.83566910 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.83206163 |
| 133 | MP0000955_abnormal_spinal_cord | 0.82884276 |
| 134 | MP0002452_abnormal_antigen_presenting | 0.82809936 |
| 135 | MP0004885_abnormal_endolymph | 0.82769392 |
| 136 | MP0002163_abnormal_gland_morphology | 0.82743676 |
| 137 | MP0008995_early_reproductive_senescence | 0.82588637 |
| 138 | MP0008872_abnormal_physiological_respon | 0.81048079 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.80739445 |
| 140 | MP0003866_abnormal_defecation | 0.77894063 |
| 141 | MP0005535_abnormal_body_temperature | 0.77221471 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.77150615 |
| 143 | MP0000733_abnormal_muscle_development | 0.76598671 |
| 144 | MP0003950_abnormal_plasma_membrane | 0.74582102 |
| 145 | MP0002177_abnormal_outer_ear | 0.74117694 |
| 146 | MP0003011_delayed_dark_adaptation | 0.73086075 |
| 147 | MP0004811_abnormal_neuron_physiology | 0.72794612 |
| 148 | MP0004085_abnormal_heartbeat | 0.72790331 |
| 149 | MP0000427_abnormal_hair_cycle | 0.72050353 |
| 150 | MP0002638_abnormal_pupillary_reflex | 0.71484546 |
| 151 | MP0001919_abnormal_reproductive_system | 0.71094756 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.70285934 |
| 153 | MP0002282_abnormal_trachea_morphology | 0.70034255 |
| 154 | MP0002116_abnormal_craniofacial_bone | 0.69786522 |
| 155 | MP0000383_abnormal_hair_follicle | 0.68241024 |
| 156 | MP0002133_abnormal_respiratory_system | 0.67690106 |
| 157 | MP0005388_respiratory_system_phenotype | 0.67690106 |
| 158 | MP0000163_abnormal_cartilage_morphology | 0.67194725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the renal collecting system (HP:0004742) | 6.32210804 |
| 2 | Genetic anticipation (HP:0003743) | 6.26476146 |
| 3 | Stenosis of the external auditory canal (HP:0000402) | 6.17891765 |
| 4 | Abnormality of cochlea (HP:0000375) | 5.95426692 |
| 5 | Lip pit (HP:0100267) | 5.86767035 |
| 6 | Morphological abnormality of the middle ear (HP:0008609) | 5.75851749 |
| 7 | Morphological abnormality of the inner ear (HP:0011390) | 4.68789175 |
| 8 | Focal motor seizures (HP:0011153) | 4.14288518 |
| 9 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.97299889 |
| 10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.97299889 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.93630194 |
| 12 | Agitation (HP:0000713) | 3.80203749 |
| 13 | Parakeratosis (HP:0001036) | 3.76334227 |
| 14 | Down-sloping shoulders (HP:0200021) | 3.74796595 |
| 15 | Abolished electroretinogram (ERG) (HP:0000550) | 3.53307491 |
| 16 | Goiter (HP:0000853) | 3.53014983 |
| 17 | Acute necrotizing encephalopathy (HP:0006965) | 3.52434086 |
| 18 | Hypothermia (HP:0002045) | 3.50057371 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.47227344 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 3.43986305 |
| 21 | Atonic seizures (HP:0010819) | 3.41577935 |
| 22 | Sensory axonal neuropathy (HP:0003390) | 3.29965132 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.24951072 |
| 24 | Decreased circulating renin level (HP:0003351) | 3.22240752 |
| 25 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.20250828 |
| 26 | True hermaphroditism (HP:0010459) | 3.20023675 |
| 27 | Pancreatic cysts (HP:0001737) | 3.19184604 |
| 28 | Pendular nystagmus (HP:0012043) | 3.19152512 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 3.12941390 |
| 30 | Porencephaly (HP:0002132) | 3.12103898 |
| 31 | Progressive macrocephaly (HP:0004481) | 3.11309330 |
| 32 | Epileptic encephalopathy (HP:0200134) | 3.10211153 |
| 33 | Pancreatic fibrosis (HP:0100732) | 3.07547387 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.06531017 |
| 35 | Abnormal hair whorl (HP:0010721) | 3.01224861 |
| 36 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.00032009 |
| 37 | Confusion (HP:0001289) | 2.99075011 |
| 38 | Hemiplegia (HP:0002301) | 2.96776179 |
| 39 | Retinal dysplasia (HP:0007973) | 2.95206670 |
| 40 | Abnormality of the axillary hair (HP:0100134) | 2.94841197 |
| 41 | Abnormality of secondary sexual hair (HP:0009888) | 2.94841197 |
| 42 | Hepatocellular necrosis (HP:0001404) | 2.92529532 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 2.92366009 |
| 44 | Conjunctival hamartoma (HP:0100780) | 2.89632144 |
| 45 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.86531132 |
| 46 | Preauricular pit (HP:0004467) | 2.86270914 |
| 47 | Periauricular skin pits (HP:0100277) | 2.86270914 |
| 48 | Hyperventilation (HP:0002883) | 2.82669739 |
| 49 | Chronic otitis media (HP:0000389) | 2.77342863 |
| 50 | Short 4th metacarpal (HP:0010044) | 2.77196232 |
| 51 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.77196232 |
| 52 | Bone cyst (HP:0012062) | 2.76666542 |
| 53 | Mixed hearing impairment (HP:0000410) | 2.72968072 |
| 54 | Increased CSF lactate (HP:0002490) | 2.71096913 |
| 55 | Nasolacrimal duct obstruction (HP:0000579) | 2.69583294 |
| 56 | Acute encephalopathy (HP:0006846) | 2.62858069 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61759953 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.60641234 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.60189277 |
| 60 | Focal seizures (HP:0007359) | 2.58589461 |
| 61 | Hamartoma of the eye (HP:0010568) | 2.58081691 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.54508469 |
| 63 | Broad-based gait (HP:0002136) | 2.53834608 |
| 64 | Asplenia (HP:0001746) | 2.51006164 |
| 65 | Peripheral hypomyelination (HP:0007182) | 2.50225151 |
| 66 | Progressive inability to walk (HP:0002505) | 2.50050800 |
| 67 | Febrile seizures (HP:0002373) | 2.48470745 |
| 68 | Impaired smooth pursuit (HP:0007772) | 2.46817427 |
| 69 | Furrowed tongue (HP:0000221) | 2.45216325 |
| 70 | Akinesia (HP:0002304) | 2.42651383 |
| 71 | Abnormality of the nasal septum (HP:0000419) | 2.41927415 |
| 72 | Leukodystrophy (HP:0002415) | 2.41299539 |
| 73 | 3-Methylglutaconic aciduria (HP:0003535) | 2.41220370 |
| 74 | Scanning speech (HP:0002168) | 2.40416215 |
| 75 | Hemiparesis (HP:0001269) | 2.38023023 |
| 76 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37169308 |
| 77 | Dialeptic seizures (HP:0011146) | 2.36417703 |
| 78 | Visual hallucinations (HP:0002367) | 2.36392640 |
| 79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35692177 |
| 80 | Exertional dyspnea (HP:0002875) | 2.35078002 |
| 81 | Nephronophthisis (HP:0000090) | 2.34531842 |
| 82 | Patchy hypopigmentation of hair (HP:0011365) | 2.33761199 |
| 83 | Absence seizures (HP:0002121) | 2.33420406 |
| 84 | Abnormality of the nasolacrimal system (HP:0000614) | 2.32953252 |
| 85 | Increased corneal curvature (HP:0100692) | 2.32832754 |
| 86 | Keratoconus (HP:0000563) | 2.32832754 |
| 87 | Decreased central vision (HP:0007663) | 2.31480552 |
| 88 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.30764916 |
| 89 | Cerebral hemorrhage (HP:0001342) | 2.30599561 |
| 90 | Increased serum pyruvate (HP:0003542) | 2.27899332 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.27899332 |
| 92 | Incomplete penetrance (HP:0003829) | 2.27690755 |
| 93 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27472042 |
| 94 | Congenital, generalized hypertrichosis (HP:0004540) | 2.25738792 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25658719 |
| 96 | Slow saccadic eye movements (HP:0000514) | 2.23563570 |
| 97 | Metabolic alkalosis (HP:0200114) | 2.21896857 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21098419 |
| 99 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.20713062 |
| 100 | White forelock (HP:0002211) | 2.20326280 |
| 101 | Optic disc pallor (HP:0000543) | 2.19380204 |
| 102 | Renal dysplasia (HP:0000110) | 2.19236714 |
| 103 | Abnormality of renal resorption (HP:0011038) | 2.19183681 |
| 104 | Recurrent abscess formation (HP:0002722) | 2.19091921 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18656021 |
| 106 | Autoamputation (HP:0001218) | 2.18616759 |
| 107 | Severe visual impairment (HP:0001141) | 2.17229382 |
| 108 | Abnormality of the lacrimal duct (HP:0011481) | 2.16926701 |
| 109 | Cystic liver disease (HP:0006706) | 2.16835813 |
| 110 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.16429346 |
| 111 | Dysmetria (HP:0001310) | 2.16393664 |
| 112 | Spastic gait (HP:0002064) | 2.16041444 |
| 113 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.13302684 |
| 114 | Limb dystonia (HP:0002451) | 2.12255657 |
| 115 | Short femoral neck (HP:0100864) | 2.09622528 |
| 116 | Inability to walk (HP:0002540) | 2.09088905 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08300250 |
| 118 | Truncal obesity (HP:0001956) | 2.07206709 |
| 119 | Abnormality of the 4th metacarpal (HP:0010012) | 2.07004619 |
| 120 | Papilledema (HP:0001085) | 2.06363246 |
| 121 | Diplopia (HP:0000651) | 2.06045871 |
| 122 | Abnormality of binocular vision (HP:0011514) | 2.06045871 |
| 123 | Methylmalonic aciduria (HP:0012120) | 2.04565369 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 2.04440145 |
| 125 | Abnormality of homocysteine metabolism (HP:0010919) | 2.04248622 |
| 126 | Homocystinuria (HP:0002156) | 2.04248622 |
| 127 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.03026295 |
| 128 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.02155756 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 2.01621152 |
| 130 | Abnormality of midbrain morphology (HP:0002418) | 2.01621152 |
| 131 | Myokymia (HP:0002411) | 2.01017313 |
| 132 | Hepatic necrosis (HP:0002605) | 1.99917266 |
| 133 | Truncal ataxia (HP:0002078) | 1.98714460 |
| 134 | Skin pits (HP:0100276) | 1.97931304 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.97906258 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 1.97491404 |
| 137 | Male pseudohermaphroditism (HP:0000037) | 1.97266969 |
| 138 | Purpura (HP:0000979) | 1.96962581 |
| 139 | Clumsiness (HP:0002312) | 1.96234820 |
| 140 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.93715101 |
| 141 | Cupped ear (HP:0000378) | 1.93475582 |
| 142 | Medial flaring of the eyebrow (HP:0010747) | 1.93457393 |
| 143 | Long nose (HP:0003189) | 1.92051840 |
| 144 | Fair hair (HP:0002286) | 1.91316369 |
| 145 | Short hallux (HP:0010109) | 1.90473023 |
| 146 | Stomatitis (HP:0010280) | 1.89911875 |
| 147 | Progressive cerebellar ataxia (HP:0002073) | 1.89747636 |
| 148 | Irregular vertebral endplates (HP:0003301) | 1.89048175 |
| 149 | Action tremor (HP:0002345) | 1.88271500 |
| 150 | Type II lissencephaly (HP:0007260) | 1.88210528 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86683383 |
| 152 | Respiratory difficulties (HP:0002880) | 1.86194261 |
| 153 | Generalized tonic-clonic seizures (HP:0002069) | 1.85485974 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.85001575 |
| 155 | Small hand (HP:0200055) | 1.84430997 |
| 156 | Restlessness (HP:0000711) | 1.83487903 |
| 157 | Meningioma (HP:0002858) | 1.83116310 |
| 158 | Neuroendocrine neoplasm (HP:0100634) | 1.82953571 |
| 159 | Absent/shortened dynein arms (HP:0200106) | 1.82945339 |
| 160 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.82945339 |
| 161 | Gait imbalance (HP:0002141) | 1.81698141 |
| 162 | Thyroiditis (HP:0100646) | 1.80225186 |
| 163 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.80106988 |
| 164 | Congenital stationary night blindness (HP:0007642) | 1.79889734 |
| 165 | Anxiety (HP:0000739) | 1.79171267 |
| 166 | Widely spaced teeth (HP:0000687) | 1.78073202 |
| 167 | Short tibia (HP:0005736) | 1.77682150 |
| 168 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77399487 |
| 169 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.76975600 |
| 170 | Chronic sinusitis (HP:0011109) | 1.76753317 |
| 171 | Abnormal pupillary function (HP:0007686) | 1.76363494 |
| 172 | Recurrent skin infections (HP:0001581) | 1.76345834 |
| 173 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.76245394 |
| 174 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74818584 |
| 175 | Obstructive lung disease (HP:0006536) | 1.74818584 |
| 176 | Chronic hepatic failure (HP:0100626) | 1.74622529 |
| 177 | Thickened helices (HP:0000391) | 1.73789287 |
| 178 | Protruding tongue (HP:0010808) | 1.73778977 |
| 179 | Abnormality of the right ventricle (HP:0001707) | 1.73419444 |
| 180 | Psychosis (HP:0000709) | 1.71504365 |
| 181 | Petechiae (HP:0000967) | 1.71361905 |
| 182 | Tinnitus (HP:0000360) | 1.70903457 |
| 183 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.70745128 |
| 184 | Respiratory failure (HP:0002878) | 1.69670378 |
| 185 | Abnormal ciliary motility (HP:0012262) | 1.68239824 |
| 186 | X-linked dominant inheritance (HP:0001423) | 1.66792631 |
| 187 | Panhypogammaglobulinemia (HP:0003139) | 1.66724339 |
| 188 | Insidious onset (HP:0003587) | 1.66009502 |
| 189 | Termporal pattern (HP:0011008) | 1.66009502 |
| 190 | Polyphagia (HP:0002591) | 1.65732705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.14556672 |
| 2 | TNIK | 3.81591343 |
| 3 | GRK1 | 3.56072820 |
| 4 | CASK | 3.23835479 |
| 5 | MAP3K12 | 3.14458083 |
| 6 | CDK19 | 3.07596149 |
| 7 | PRKD2 | 3.02768446 |
| 8 | STK39 | 2.95788566 |
| 9 | OXSR1 | 2.76900391 |
| 10 | RIPK4 | 2.69995811 |
| 11 | PINK1 | 2.45074862 |
| 12 | MAPKAPK5 | 2.25765009 |
| 13 | MAP2K7 | 2.07365021 |
| 14 | TLK1 | 1.86579431 |
| 15 | KIT | 1.78252379 |
| 16 | INSRR | 1.76626868 |
| 17 | FES | 1.75901332 |
| 18 | STK16 | 1.74933116 |
| 19 | GRK7 | 1.74595935 |
| 20 | DAPK2 | 1.71286693 |
| 21 | NUAK1 | 1.71008665 |
| 22 | SGK2 | 1.67050215 |
| 23 | MST4 | 1.65004559 |
| 24 | BMPR1B | 1.60198490 |
| 25 | PNCK | 1.58909450 |
| 26 | ACVR1B | 1.56201419 |
| 27 | EPHA4 | 1.54053422 |
| 28 | ADRBK2 | 1.53347270 |
| 29 | MUSK | 1.50904358 |
| 30 | EPHB1 | 1.47455512 |
| 31 | NTRK3 | 1.43362601 |
| 32 | AKT3 | 1.38065045 |
| 33 | BMPR2 | 1.37442474 |
| 34 | CSNK1G3 | 1.31392009 |
| 35 | BCR | 1.29537649 |
| 36 | FGR | 1.27953896 |
| 37 | IRAK4 | 1.25240731 |
| 38 | MAP3K4 | 1.24253797 |
| 39 | ARAF | 1.22129970 |
| 40 | TXK | 1.21631882 |
| 41 | ERBB2 | 1.17787846 |
| 42 | CLK1 | 1.15911996 |
| 43 | PKN1 | 1.15848971 |
| 44 | MAP3K13 | 1.15737325 |
| 45 | UHMK1 | 1.15360136 |
| 46 | PLK2 | 1.14603532 |
| 47 | CAMK2B | 1.14393984 |
| 48 | NTRK1 | 1.14309549 |
| 49 | SYK | 1.13083353 |
| 50 | MAP3K9 | 1.12837151 |
| 51 | GRK5 | 1.11208063 |
| 52 | CSNK1G2 | 1.08883245 |
| 53 | NLK | 1.07040758 |
| 54 | MAPK13 | 1.06910900 |
| 55 | CAMKK2 | 1.05257888 |
| 56 | PRPF4B | 1.05190126 |
| 57 | TEC | 1.04799633 |
| 58 | TAF1 | 1.01740799 |
| 59 | MAP4K1 | 0.99454119 |
| 60 | EPHA3 | 0.98978542 |
| 61 | RPS6KA2 | 0.97867235 |
| 62 | RPS6KA6 | 0.97840750 |
| 63 | GRK6 | 0.97550113 |
| 64 | CAMK2A | 0.94734440 |
| 65 | STK11 | 0.93016122 |
| 66 | PRKCG | 0.90605339 |
| 67 | PAK3 | 0.88572070 |
| 68 | CSNK1A1L | 0.88322469 |
| 69 | MAPK15 | 0.88008660 |
| 70 | CAMK2D | 0.86795371 |
| 71 | MINK1 | 0.85827526 |
| 72 | PRKCQ | 0.85452956 |
| 73 | SGK1 | 0.84384293 |
| 74 | IKBKB | 0.82350218 |
| 75 | CSNK1G1 | 0.81052163 |
| 76 | NEK6 | 0.79851374 |
| 77 | PIM2 | 0.79532422 |
| 78 | ROCK2 | 0.79365497 |
| 79 | CSF1R | 0.79147879 |
| 80 | BLK | 0.79071037 |
| 81 | SGK3 | 0.79061790 |
| 82 | MAP3K6 | 0.78593936 |
| 83 | CDK5 | 0.78074224 |
| 84 | LCK | 0.75833792 |
| 85 | MAP3K7 | 0.75470605 |
| 86 | MATK | 0.74012844 |
| 87 | FGFR3 | 0.73683030 |
| 88 | PRKCE | 0.73198194 |
| 89 | PBK | 0.72572650 |
| 90 | BTK | 0.70677399 |
| 91 | VRK1 | 0.70164013 |
| 92 | TNK2 | 0.69371232 |
| 93 | PRKCH | 0.68979624 |
| 94 | MAP2K4 | 0.68617297 |
| 95 | LYN | 0.67443234 |
| 96 | MAP3K14 | 0.67272333 |
| 97 | CAMK4 | 0.66855577 |
| 98 | NME1 | 0.66690661 |
| 99 | IKBKE | 0.66556376 |
| 100 | SIK3 | 0.66512599 |
| 101 | NTRK2 | 0.66352023 |
| 102 | RPS6KL1 | 0.66216714 |
| 103 | RPS6KC1 | 0.66216714 |
| 104 | YES1 | 0.65812782 |
| 105 | WNK4 | 0.64810348 |
| 106 | MARK2 | 0.64261459 |
| 107 | MAPKAPK3 | 0.62347286 |
| 108 | RAF1 | 0.61882831 |
| 109 | ADRBK1 | 0.61698459 |
| 110 | DAPK1 | 0.61547218 |
| 111 | MARK1 | 0.61449288 |
| 112 | PRKD1 | 0.61040722 |
| 113 | HCK | 0.60460921 |
| 114 | CHUK | 0.59190080 |
| 115 | CAMKK1 | 0.58127910 |
| 116 | TRPM7 | 0.57318667 |
| 117 | SGK223 | 0.55503538 |
| 118 | SGK494 | 0.55503538 |
| 119 | PRKACA | 0.54651694 |
| 120 | ITK | 0.53993229 |
| 121 | CAMK2G | 0.53959459 |
| 122 | PTK2B | 0.53957482 |
| 123 | FYN | 0.53543274 |
| 124 | PIK3CA | 0.53360785 |
| 125 | RPS6KA5 | 0.53105663 |
| 126 | CDK3 | 0.53079041 |
| 127 | CSNK1A1 | 0.51472388 |
| 128 | MAP4K2 | 0.50429783 |
| 129 | PRKCZ | 0.49127416 |
| 130 | ABL1 | 0.49116288 |
| 131 | FGFR2 | 0.49034920 |
| 132 | IGF1R | 0.48849818 |
| 133 | MAPK4 | 0.47265423 |
| 134 | MYLK | 0.46990914 |
| 135 | TIE1 | 0.46897248 |
| 136 | CDK14 | 0.46695357 |
| 137 | DYRK2 | 0.46645675 |
| 138 | WNK3 | 0.46314474 |
| 139 | PRKG1 | 0.46027753 |
| 140 | PRKCA | 0.43288092 |
| 141 | DYRK1A | 0.42641465 |
| 142 | JAK1 | 0.42527853 |
| 143 | PDGFRB | 0.41645799 |
| 144 | MAPK7 | 0.41638036 |
| 145 | WNK1 | 0.41344948 |
| 146 | SIK2 | 0.40708114 |
| 147 | CCNB1 | 0.40428051 |
| 148 | CDK18 | 0.40357424 |
| 149 | CAMK1 | 0.40160688 |
| 150 | HIPK2 | 0.39706584 |
| 151 | CDK11A | 0.39313137 |
| 152 | TAOK3 | 0.39262839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.37966950 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.88028508 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.58839013 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44456827 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.41577723 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.37027224 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.31354871 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19764597 |
| 9 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.10868404 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.01051001 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.90491934 |
| 12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.88307080 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.86369827 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81528511 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.79384494 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.75251742 |
| 17 | Melanoma_Homo sapiens_hsa05218 | 1.72089061 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71124915 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.68258649 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65022916 |
| 21 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.63164971 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.57630924 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.53689365 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52099850 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.51447988 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.50315594 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.48527193 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47031545 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46811127 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45568446 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44336180 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.41951640 |
| 33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.38384411 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36643795 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35680017 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31390433 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.30633633 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.28503277 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24514136 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22097172 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18778512 |
| 42 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.17951812 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16217680 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14423860 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12746977 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11807097 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10161648 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 1.09949772 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09888678 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09554446 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08155715 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.04803599 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03505306 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02462498 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02374979 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00146538 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99583877 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99500127 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98979608 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.98357436 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.96698847 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95906528 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95294002 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90548600 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89443623 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88520847 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.88302758 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87541121 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.85036404 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84119658 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83122705 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.81600098 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78972744 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78945539 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77502185 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75703346 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.75324558 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74523726 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73613734 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73599456 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.73507523 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72828180 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.71168884 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71166561 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70430818 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.70273891 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67736144 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66379989 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66232293 |
| 90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65110367 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.63663536 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63285038 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63177258 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62196994 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61306725 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61035170 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.60617413 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59732720 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59569341 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59484901 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59298758 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59108039 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57998268 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57478033 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57130403 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57032483 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56991564 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55553698 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55495096 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.53882698 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53043830 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52670681 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51729850 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51482120 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.51479109 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.50801562 |
| 117 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50578929 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50305734 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50133008 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48803051 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48737783 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47860326 |
| 123 | Insulin secretion_Homo sapiens_hsa04911 | 0.47226965 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.47172923 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46958141 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46460862 |
| 127 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46307145 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45321318 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44874048 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.44734940 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43778465 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.42803569 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42233621 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41559516 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41227451 |
| 136 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39620477 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.39543067 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39255791 |
| 139 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39209310 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38636009 |
| 141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37963235 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35799521 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33309084 |

